Potassium carbonate structure 
             | 
        Common Name | Potassium carbonate | ||
|---|---|---|---|---|
| CAS Number | 584-08-7 | Molecular Weight | 138.21 | |
| Density | 2.43 g/mL at 25 °C | Boiling Point | 333.6ºC at 760 mmHg | |
| Molecular Formula | CK2O3 | Melting Point | 891 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 111ºC | |
| Symbol | 
             
            
            GHS07  | 
        Signal Word | Warning | |
            Use of Potassium carbonateAnhydrous potassium carbonate, 99.995% metals basis is a biochemical reagent that can be used as a biological material or organic compound for life science related research.  | 
    
| Name | Potassium carbonate | 
|---|---|
| Synonym | More Synonyms | 
| Description | Anhydrous potassium carbonate, 99.995% metals basis is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | 
|---|---|
| Related Catalog | |
| In Vitro | Potassium carbonate 具有广泛的工业和研究应用。碳酸钾的主要用途是制造化学品、化肥、肥皂和玻璃。它用作溶剂的干燥剂,特别是在存在痕量酸的情况下,以及用作有机合成中产生的酸的清除剂。它在葡萄酒生产过程中用作缓冲剂。它也被用作灭火器中的灭火剂。在有机合成中,它是广泛用于碳、硫、氮和氧中心的烷基化和芳基化反应的试剂。它还用于醛醇缩合、Michael 反应、酰化、Wittig 反应、Knoevenagel 反应、消除反应、环氧树脂开环、循环、金属催化的交叉偶联反应、水合和多种反应。 | 
| Density | 2.43 g/mL at 25 °C | 
|---|---|
| Boiling Point | 333.6ºC at 760 mmHg | 
| Melting Point | 891 °C(lit.) | 
| Molecular Formula | CK2O3 | 
| Molecular Weight | 138.21 | 
| Flash Point | 111ºC | 
| Exact Mass | 137.912155 | 
| PSA | 63.19000 | 
| Storage condition | Store at RT. | 
| Stability | Stable. Incompatible with moisture, acids, magnesium bromine trifluoride and magnesium bromine trichloride. | 
| Water Solubility | 1120 g/L (20 ºC) | 
                                    CHEMICAL IDENTIFICATION
 
 
 
 
 
 
 HEALTH HAZARD DATAACUTE TOXICITY DATA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 MUTATION DATA
 
 
  | 
                            
| Symbol | 
                                    
                                     
                                    
                                    GHS07  | 
                            
|---|---|
| Signal Word | Warning | 
| Hazard Statements | H302-H315-H319-H335 | 
| Precautionary Statements | P261-P305 + P351 + P338 | 
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves | 
| Hazard Codes | Xn:Harmful | 
| Risk Phrases | R22;R36/37/38 | 
| Safety Phrases | S26-S36-S37/39 | 
| RIDADR | 3262 | 
| WGK Germany | 1 | 
| RTECS | TS7750000 | 
| Packaging Group | III | 
| HS Code | 2836400000 | 
| Precursor 10 | |
|---|---|
| DownStream 10 | |
| HS Code | 2836400000 | 
|---|
| 
                                    
                                    In vitro inhibition of lysine decarboxylase activity by organophosphate esters.
                                    
                                    
                                     Biochem. Pharmacol. 92(3) , 506-16, (2014) Organophosphate esters (OPEs), a major group of organophosphorus flame retardants, are regarded as emerging environmental contaminants of health concern. Amino acid decarboxylases catalyze the convers...  | 
                                |
| 
                                    
                                    Study on the phase I metabolism of novel synthetic cannabinoids, APICA and its fluorinated analogue.
                                    
                                    
                                     Drug Test. Anal. 7(2) , 131-42, (2015) The data are reported for an in vitro metabolism study of two novel synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and its fluorinated analog N-(1-adamantyl)-1-(5-flu...  | 
                                |
| 
                                    
                                    Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours.
                                    
                                    
                                     Adv. Healthc. Mater. 3(7) , 1071-7, (2014) Pulmonary immunization poses the unique challenge of balancing vaccine efficacy with minimizing inflammation in the respiratory tract. While previous studies have shown that mice immunized intranasall...  | 
                                
| MFCD00011382 | 
| POTASH | 
| Pearl dust | 
| EINECS 209-529-3 | 
| PEARL ASH | 
| dipotassium carbonic acid | 
| K-Gran | 
| Kaliumcarbonat | 
| alt of wormwood | 
| Montreal potash | 
| SALT OF TARTAR | 
| K2CO3 | 
| Sal absinthii |